| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |